Clinical trial
Topical Steroid Treatment for Eosinophilic Esophagitis
NCT00275561 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275561 |
|---|---|
| Title | Topical Steroid Treatment for Eosinophilic Esophagitis |
| Official title | A Randomized Placebo-controlled Trial of Swallowed Fluticasone in Treatment of Eosinophilic Esophagitis |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Eosinophilic Esophagitis |
| Intervention type | Drug |
| Interventions | Fluticasone, Placebo |
| Enrollment | 42 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jan 12, 2006 |
| Last update posted | May 8, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: